Analysis of clomesone in plasma by gas chromatography-electrolytic conductivity detection.
A sensitive and specific gas chromatographic (GC) method with electrolytic conductivity detection (ELD) for the analysis of clomesone (2-chloroethylmethylsulfonylmethane sulfonate), a new experimental antitumor alkylating agent, in plasma has been developed for the first time. Clomesone in plasma containing suitable internal standard was extracted with methylene chloride. After evaporation, the residue was analyzed by GC-ELD. Either a 15-m wide-bore DB-17 or a DB-1 column with the corresponding internal standards of propachlor or butachlor, respectively, was used. For the DB-1 column with butachlor as the internal standard, the routine assay limit was 20 ng/ml with linearity from 10 to 2000 ng/ml monitored. The within-run coefficient of variation of eight replicates at 50 ng/ml was 8.0% and the between-run coefficient of variation was 11% at 120 ng/ml. Using this assay procedure, the stability in several aqueous media and protein binding of clomesone were evaluated. In fresh mouse plasma, the half-life of clomesone was less than 1 h, although in aged pooled human plasma the drug was more stable. The mean protein binding value in mouse and human plasma was about 81-85%.
Chan
K K
KK
School of Pharmacy, University of Southern California, Los Angeles 90033.
Barrientos
A
A
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood*; D001798:Blood Proteins / Q000378:metabolism; D002849:Chromatography, Gas; D004553:Electric Conductivity; D006207:Half-Life; D006801:Humans; D007202:Indicators and Reagents; D008698:Mesylates / Q000097:blood*; D051379:Mice; D008815:Mice, Inbred Strains; D011485:Protein Binding; D012015:Reference Standards
D000970:Antineoplastic Agents; D001798:Blood Proteins; D007202:Indicators and Reagents; D008698:Mesylates; C041189:clomesone